App-Quantinova.ai

Characteristics of patients with and without dialysis dependent chronic kidney disease and anemia receiving blood transfusions and intravenous iron: A report from the DISCOVER CKD retrospective cohort

Eric Wittbrodt - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

N/A

Patients? and physicians? preferences for treatment of anemia of chronic kidney disease: design methods of a discrete choice experiment

Ember Lu - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal anemia

N/A

Long-term Safety and Efficacy of Difelikefalin in Patients With Chronic Kidney Disease?Associated Pruritus: Analysis From KALM-1 and KALM-2

Steven Fishbane - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Uraemic pruritus

Difelikefalin

Inflammatory response within the nervous system in Tat induced HIV-associated sensory neuropathy

Ling Cao - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Peripheral Nervous System

Peripheral neuropathy

Doxycycline

Changes in peripheral intraepidermal nerve fiber densities in CD137 ligand – mediated neuropathic pain following sciatic nerve crush

Ethan E Jordan - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Pain (neuropathic)

CGRP

DNA-PK senses DNA virus infection in human cells

Brian J Ferguson - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Herpes simplex virus infection

Interferon

Phosphatidylserine Receptor Enhancement of SARS-CoV-2 Entry: AXL as a Therapeutic Target for COVID-19

Dana Bohan - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Phosphatidylserine

Integration of affinity and abundance parameters for the identification of novel CD8+ T cell specificities in the CT26 tumor model

David Arcia - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The immunological profile of maternal obesity at 28 weeks gestation underpins common negative pregnancy outcomes

April Rees - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Gestational Diabetes

N/A

Oxytocin is required for remote learning. Students need a bonding-hormone to improve their learning.

Nadeem Fazal - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Oxytocin

The global digital divide: Younger and older teachers at odds in this COVID19-induced remote teaching experiment.

Nadeem Fazal - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronavirus disease

N/A

Old is Gold! Old School is Back to a New School of Learning.

Nadeem Fazal - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The origin and fate of malaria-associated atypical memory B cells

Evelien M Bunnik - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Malaria

N/A

Plasmodium falciparum-specific B cell responses in malaria-susceptible children and malaria-immune adults

Stephen Jacob Gonzales - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Malaria

N/A

The development of peripheral intraepithelial lymphocytes in vivo is influenced by microbial metabolites

Amelia T Soderholm - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

The C3-like molecule CD109 controls Th1 versus Th17 induction in CD4+ T cells

Nicolas S Merle - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Interferon Gamma

Loss of C3aR induces immune infiltration and inflammatory microbiota in a new spontaneous model of colon cancer

Silvia Guglietta - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Oral mucosal IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral candidiasis

Felix E.Y. Aggor - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Accelerating ADCP screening using the iQue® Advanced Flow Cytometry Platform

Kirsty A McBain - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Analysis of the role of helminth TGF-β mimic in tissue repair.

Katherine E Lothstein - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Filters

45280 Abstracts